Crossroads Capital has sold its entire position in Calumet Specialty Products Partners (CLMT), marking a strategic exit from the midstream energy play. The divestment follows broader portfolio adjustments in the energy sector.
- Crossroads Capital sold 1.8 million shares of CLMT in March 2026, exiting entirely
- CLMT reported $197 million in Q4 2025 cash flow and a 6.4% dividend yield
- XLE declined 2.3% during the same period amid sector-wide rebalancing
- CL=F settled at $78 per barrel, reflecting soft demand outlooks
- CLMT stock dipped 1.7% post-sale with 38% elevated trading volume
- CLMT maintains a 2.9x debt-to-EBITDA ratio and 45% payout ratio
Crossroads Capital recently unloaded its full stake in Calumet Specialty Products Partners (CLMT), removing approximately 1.8 million shares from its holdings. The transaction, finalized in early March 2026, represents a shift in the firm’s energy sector allocation, with no remaining exposure to CLMT reported in the latest Form 13F filing. The move comes as Crossroads Capital reevaluates its exposure to refining and specialty chemicals following a period of margin compression in the downstream energy segment. Despite CLMT’s stable dividend yield of 6.4% and strong cash flow generation of $197 million in Q4 2025, the firm cited reduced long-term growth visibility as a key factor in the decision. The sale coincided with a broader realignment of energy ETFs, including XLE, which saw a 2.3% decline over the same period. Crude oil futures (CL=F) stabilized near $78 per barrel, reflecting muted demand forecasts and increased supply from OPEC+. This environment likely influenced investor sentiment toward midstream equities. The divestment has triggered a modest 1.7% drop in CLMT’s stock price on March 2, 2026, with trading volume spiking 38% above average. However, market analysts note that the impact is isolated, as CLMT’s fundamentals remain intact, with a debt-to-EBITDA ratio of 2.9x and a 45% payout ratio, indicating sustainable distribution coverage.